Molecular mechanisms in renal degenerative disease

Seminars in Cell and Developmental Biology

Volumn 21, Issue 8, 2010, Pages 831-837

  Vasyutina, Elena ^a   Treier, Mathias ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cilia; CKD; Fibrosis; Kidney; Nephronophthisis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BONE MORPHOGENETIC PROTEIN; CHEMOKINE; CYTOKINE; POLYCYSTIN; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CELL ORGANELLE; CELL POLARITY; CHRONIC KIDNEY DISEASE; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; HOMEOSTASIS; HUMAN; KIDNEY FIBROSIS; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE EPITHELIUM; MACROPHAGE; MYOFIBROBLAST; NEPHRONOPHTHITIS; PATHOPHYSIOLOGY; PRIMARY CILIUM; REVIEW; SIGNAL TRANSDUCTION;

EID: 78049242957     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2010.08.010     Document Type: Review

References (88)

1. Eyden B. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008, 12:22-37.
2. Grande M.T., Lopez-Novoa J.M. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 2009, 5:319-328.
3. Iwano M., Plieth D., Danoff T.M., Xue C., Okada H., Neilson E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002, 110:341-350.
4. Zeisberg E.M., Potenta S.E., Sugimoto H., Zeisberg M., Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008, 19:2282-2287.
5. Broekema M., Harmsen M.C., van Luyn M.J., Koerts J.A., Petersen A.H., van Kooten T.G., et al. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats. J Am Soc Nephrol 2007, 18:165-175.
6. Humphreys B.D., Lin S.L., Kobayashi A., Hudson T.E., Nowlin B.T., Bonventre J.V., et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010, 176:85-97.
7. Koesters R., Kaissling B., Lehir M., Picard N., Theilig F., Gebhardt R., et al. Tubular overexpression of transforming growth factor-β1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010, 177:632-643.
8. Zeisberg M., Duffield J.S. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010, 21:1247-1253.
9. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
10. Fischer E., Pontoglio M. Planar cell polarity and cilia. Semin Cell Dev Biol 2009, 20:998-1005.
11. Singla V., Reiter J.F. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science 2006, 313:629-633.
12. Zhou J. Polycystins and primary cilia: primers for cell cycle progression. Annu Rev Physiol 2009, 71:83-113.
13. Delmas P. Polycystins: from mechanosensation to gene regulation. Cell 2004, 118:145-148.
14. Hildebrandt F., Attanasio M., Otto E. Nephronophthisis: disease mechanisms of a ciliopathy. J Am Soc Nephrol 2009, 20:23-35.
15. Grigoryan T., Wend P., Klaus A., Birchmeier W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev 2008, 22:2308-2341.
16. Lal M., Song X., Pluznick J.L., Di Giovanni V., Merrick D.M., Rosenblum N.D., et al. Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. Hum Mol Genet 2008, 17:3105-3117.
17. Bergmann C., Fliegauf M., Bruchle N.O., Frank V., Olbrich H., Kirschner J., et al. Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia. Am J Hum Genet 2008, 82:959-970.
18. Simons M., Gloy J., Ganner A., Bullerkotte A., Bashkurov M., Kronig C., et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet 2005, 37:537-543.
19. Corbit K.C., Shyer A.E., Dowdle W.E., Gaulden J., Singla V., Chen M.H., et al. Kif3a constrains beta-catenin-dependent Wnt signaling through dual ciliary and non-ciliary mechanisms. Nat Cell Biol 2008, 10:70-76.
20. He W., Dai C., Li Y., Zeng G., Monga S.P., Liu Y. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 2009, 20:765-776.
21. Surendran K., Schiavi S., Hruska K.A. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 2005, 16:2373-2384.
22. Lin S.L., Li B., Rao S., Yeo E.J., Hudson T.E., Nowlin B.T., et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci USA 2010, 107:4194-4199.
23. Lancaster M.A., Louie C.M., Silhavy J.L., Sintasath L., Decambre M., Nigam S.K., et al. Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat Med 2009, 15:1046-1054.
24. Barrow J.R. Wnt/PCP signaling: a veritable polar star in establishing patterns of polarity in embryonic tissues. Semin Cell Dev Biol 2006, 17:185-193.
25. Fischer E., Legue E., Doyen A., Nato F., Nicolas J.F., Torres V., et al. Defective planar cell polarity in polycystic kidney disease. Nat Genet 2006, 38:21-23.
26. Karner C.M., Chirumamilla R., Aoki S., Igarashi P., Wallingford J.B., Carroll T.J. Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis. Nat Genet 2009, 41:793-799.
27. Saburi S., Hester I., Fischer E., Pontoglio M., Eremina V., Gessler M., et al. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat Genet 2008, 40:1010-1015.
28. Battini L., Macip S., Fedorova E., Dikman S., Somlo S., Montagna C., et al. Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum Mol Genet 2008, 17:2819-2833.
29. Burtey S., Riera M., Ribe E., Pennenkamp P., Rance R., Luciani J., et al. Centrosome overduplication and mitotic instability in PKD2 transgenic lines. Cell Biol Int 2008, 32:1193-1198.
30. Wong S.Y., Reiter J.F. The primary cilium at the crossroads of mammalian hedgehog signaling. Curr Top Dev Biol 2008, 85:225-260.
31. Quinlan R.J., Tobin J.L., Beales P.L. Modeling ciliopathies: primary cilia in development and disease. Curr Top Dev Biol 2008, 84:249-310.
32. Eggenschwiler J.T., Anderson K.V. Cilia and developmental signaling. Annu Rev Cell Dev Biol 2007, 23:345-373.
33. Gill P.S., Rosenblum N.D. Control of murine kidney development by sonic hedgehog and its GLI effectors. Cell Cycle 2006, 5:1426-1430.
34. Cain J.E., Islam E., Haxho F., Chen L., Bridgewater D., Nieuwenhuis E., et al. GLI3 repressor controls nephron number via regulation of Wnt11 and Ret in ureteric tip cells. PLoS One 2009, 4:e7313.
35. Hu M.C., Mo R., Bhella S., Wilson C.W., Chuang P.T., Hui C.C., et al. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis. Development 2006, 133:569-578.
36. Yu J., Carroll T.J., McMahon A.P. Sonic hedgehog regulates proliferation and differentiation of mesenchymal cells in the mouse metanephric kidney. Development 2002, 129:5301-5312.
37. Bose J., Grotewold L., Ruther U. Pallister-Hall syndrome phenotype in mice mutant for Gli3. Hum Mol Genet 2002, 11:1129-1135.
38. Dormoy V., Danilin S., Lindner V., Thomas L., Rothhut S., Coquard C., et al. The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol Cancer 2009, 8:123.
39. Kim Y.S., Nakanishi G., Lewandoski M., Jetten A.M. GLIS3, a novel member of the GLIS subfamily of Kruppel-like zinc finger proteins with repressor and activation functions. Nucleic Acids Res 2003, 31:5513-5525.
40. Zhang F., Jetten A.M. Genomic structure of the gene encoding the human GLI-related, Kruppel-like zinc finger protein GLIS2. Gene 2001, 280:49-57.
41. Zhang F., Nakanishi G., Kurebayashi S., Yoshino K., Perantoni A., Kim Y.S., et al. Characterization of Glis2, a novel gene encoding a Gli-related, Kruppel-like transcription factor with transactivation and repressor functions. Roles in kidney development and neurogenesis. J Biol Chem 2002, 277:10139-10149.
42. Attanasio M., Uhlenhaut N.H., Sousa V.H., O'Toole J.F., Otto E., Anlag K., et al. Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet 2007, 39:1018-1024.
43. Kang H.S., Beak J.Y., Kim Y.S., Herbert R., Jetten A.M. Glis3 is associated with primary cilia and Wwtr1/TAZ and implicated in polycystic kidney disease. Mol Cell Biol 2009, 29:2556-2569.
44. Kim Y.S., Kang H.S., Herbert R., Beak J.Y., Collins J.B., Grissom S.F., et al. Kruppel-like zinc finger protein Glis2 is essential for the maintenance of normal renal functions. Mol Cell Biol 2008, 28:2358-2367.
45. Senee V., Chelala C., Duchatelet S., Feng D., Blanc H., Cossec J.C., et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 2006, 38:682-687.
46. Kim Y.S., Kang H.S., Jetten A.M. The Kruppel-like zinc finger protein Glis2 functions as a negative modulator of the Wnt/beta-catenin signaling pathway. FEBS Lett 2007, 581:858-864.
47. Hosking C.R., Ulloa F., Hogan C., Ferber E.C., Figueroa A., Gevaert K., et al. The transcriptional repressor Glis2 is a novel binding partner for p120 catenin. Mol Biol Cell 2007, 18:1918-1927.
48. Vernon M.A., Mylonas K.J., Hughes J. Macrophages and renal fibrosis. Semin Nephrol 2010, 30:302-317.
49. Nathan C., Ding A. Nonresolving inflammation. Cell 2010, 140:871-882.
50. Ricardo S.D., van Goor H., Eddy A.A. Macrophage diversity in renal injury and repair. J Clin Invest 2008, 118:3522-3530.
51. Bani-Hani A.H., Leslie J.A., Asanuma H., Dinarello C.A., Campbell M.T., Meldrum D.R., et al. IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int 2009, 76:500-511.
52. Sakai N., Wada T., Yokoyama H., Lipp M., Ueha S., Matsushima K., et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006, 103:14098-14103.
53. Wei C.C., Li H.H., Hsu Y.H., Hsing C.H., Sung J.M., Chang M.S. Interleukin-20 targets renal cells and is associated with chronic kidney disease. Biochem Biophys Res Commun 2008, 374:448-453.
54. Ortiz-Munoz G., Lopez-Parra V., Lopez-Franco O., Fernandez-Vizarra P., Mallavia B., Flores C., et al. Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol 2010.
55. Lin S.L., Castano A.P., Nowlin B.T., Lupher M.L., Duffield J.S. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009, 183:6733-6743.
56. Merta M., Tesar V., Zima T., Jirsa M., Rysava R., Zabka J. Cytokine profile in autosomal dominant polycystic kidney disease. Biochem Mol Biol Int 1997, 41:619-624.
57. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006, 69:213-217.
58. Bondi C.D., Manickam N., Lee D.Y., Block K., Gorin Y., Abboud H.E., et al. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol 2010, 21:93-102.
59. Kopp J.B., Factor V.M., Mozes M., Nagy P., Sanderson N., Bottinger E.P., et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996, 74:991-1003.
60. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004, 15:1-12.
61. Verrecchia F., Chu M.L., Mauviel A. Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001, 276:17058-17062.
62. Seo J.Y., Park J., Yu M.R., Kim Y.S., Ha H., Lee H.B. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes. Am J Nephrol 2009, 30:481-490.
63. Isaka Y., Tsujie M., Ando Y., Nakamura H., Kaneda Y., Imai E., et al. Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 2000, 58:1885-1892.
64. Ziyadeh F.N., Hoffman B.B., Han D.C., Iglesias-De La Cruz M.C., Hong S.W., Isono M., et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000, 97:8015-8020.
65. Fukasawa H., Yamamoto T., Togawa A., Ohashi N., Fujigaki Y., Oda T., et al. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci USA 2004, 101:8687-8692.
66. Chung A.C., Huang X.R., Zhou L., Heuchel R., Lai K.N., Lan H.Y. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant 2009, 24:1443-1454.
67. Fujimoto M., Maezawa Y., Yokote K., Joh K., Kobayashi K., Kawamura H., et al. Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy. Biochem Biophys Res Commun 2003, 305:1002-1007.
68. Chung A.C., Huang X.R., Meng X., Lan H.Y. miR-192 mediates TGF-β/Smad3-driven renal fibrosis. J Am Soc Nephrol 2010.
69. Kato M., Putta S., Wang M., Yuan H., Lanting L., Nair I., et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009, 11:881-889.
70. Deheuninck J., Luo K. Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res 2009, 19:47-57.
71. Fukasawa H., Yamamoto T., Togawa A., Ohashi N., Fujigaki Y., Oda T., et al. Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury. Kidney Int 2006, 69:1733-1740.
72. Yang L., Besschetnova T.Y., Brooks C.R., Shah J.V., Bonventre J.V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010, 16:535-543. 1p following 143.
73. Patel S.R., Dressler G.R. BMP7 signaling in renal development and disease. Trends Mol Med 2005, 11:512-518.
74. Xu Y., Wan J., Jiang D., Wu X. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition in human renal proximal tubular epithelial cells. J Nephrol 2009, 22:403-410.
75. Wang S., Hirschberg R. Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem 2004, 279:23200-23206.
76. Yang Y.L., Liu Y.S., Chuang L.Y., Guh J.Y., Lee T.C., Liao T.N., et al. Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors. Endocrinology 2009, 150:727-740.
77. Lin J., Patel S.R., Cheng X., Cho E.A., Levitan I., Ullenbruch M., et al. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med 2005, 11:387-393.
78. Lin J., Patel S.R., Wang M., Dressler G.R. The cysteine-rich domain protein KCP is a suppressor of transforming growth factor beta/activin signaling in renal epithelia. Mol Cell Biol 2006, 26:4577-4585.
79. Tanaka M., Asada M., Higashi A.Y., Nakamura J., Oguchi A., Tomita M., et al. Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J Clin Invest 2010, 120:768-777.
80. Cao Y., Semanchik N., Lee S.H., Somlo S., Barbano P.E., Coifman R., et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci USA 2009, 106:21819-21824.
81. Noh H., Oh E.Y., Seo J.Y., Yu M.R., Kim Y.O., Ha H., et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol 2009, 297:F729-F739.
82. Zager R.A., Johnson A.C. Renal ischemia-reperfusion injury upregulates histone-modifying enzyme systems and alters histone expression at proinflammatory/profibrotic genes. Am J Physiol Renal Physiol 2009, 296:F1032-F1041.
83. Bechtel W., McGoohan S., Zeisberg E.M., Muller G.A., Kalbacher H., Salant D.J., et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010.
84. Bell C.G., Teschendorff A.E., Rakyan V.K., Maxwell A.P., Beck S., Savage D.A. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 2010, 3:33.
85. Thoma C.R., Frew I.J., Hoerner C.R., Montani M., Moch H., Krek W. pVHL and GSK3beta are components of a primary cilium-maintenance signaling network. Nat Cell Biol 2007, 9:588-595.
86. van Haaften G., Dalgliesh G.L., Davies H., Chen L., Bignell G., Greenman C., et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 2009, 41:521-523.
87. Dalgliesh G.L., Furge K., Greenman C., Chen L., Bignell G., Butler A., et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010, 463:360-363.
88. Bonafoux D., Lee W.C. Strategies for TGF-beta modulation: a review of recent patents. Expert Opin Ther Pat 2009, 19:1759-1769.